Investor's Fiduciary Advisor Network’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$889K Sell
2,528
-331
-12% -$118K 0.27% 99
2025
Q4
$935K Buy
2,859
+95
+3% +$30.1K 0.2% 113
2025
Q3
$780K Buy
2,764
+12
+0.4% +$3.48K 0.26% 98
2025
Q2
$768K Buy
2,752
+413
+18% +$117K 0.29% 95
2025
Q1
$728K Sell
2,339
-482
-17% -$142K 0.34% 79
2024
Q4
$735K Buy
+2,821
New +$837K 0.28% 89

Other funds holding AMGN

Investor's Fiduciary Advisor Network's AMGN Position: Q1 2026 in Review

Investor's Fiduciary Advisor Network reduced its Amgen (AMGN) stake by 12% in Q1 2026, selling an estimated $118K and leaving 2,528 shares worth $889K. The position accounts for 0.27% of the portfolio, ranked #99.

Investor's Fiduciary Advisor Network first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $935K in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Investor's Fiduciary Advisor Network held 2,528 shares of Amgen worth $889K as of Q1 2026.
  • Investor's Fiduciary Advisor Network sold 331 Amgen shares in Q1 2026, an estimated $118K.
  • Amgen made up 0.27% of Investor's Fiduciary Advisor Network's portfolio in Q1 2026, its #99 holding.
  • Investor's Fiduciary Advisor Network first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • Investor's Fiduciary Advisor Network's Amgen position peaked at $935K in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Investor's Fiduciary Advisor Network's 13F filing for Q1 2026, filed 12 May 2026.